NR4A1 and breast carcinoma: Building on preliminary findings indicating ARL3's potential role in modulating the biological behavior of hormone receptor‐positive (HR+) breast cancer cells, we generated stable cell lines with constitutive ARL3 overexpression and CRISPR/Cas9‐mediated knockout.